SAGE-217, A Novel GABA<sub>A</sub> Receptor Positive Allosteric Modulator: Clinical Pharmacology and Tolerability in Randomized Phase I Dose-Finding Studies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Works by Wald, Jeff
Results: 6
1
2
Pharmacokinetics of Oral Recombinant Human Parathyroid Hormone [rhPTH(1-31)NH] in Postmenopausal Women with Osteoporosis.
- Published in:
- Clinical Pharmacokinetics, 2013, v. 52, n. 11, p. 995, doi. 10.1007/s40262-013-0083-4
- By:
- Publication type:
- Article
3
Pharmacokinetics of oral recombinant human parathyroid hormone [rhPTH(1-31)NH₂] in postmenopausal women with osteoporosis.
- Published in:
- 2013
- By:
- Publication type:
- journal article
4
Dalzanemdor (SAGE‐718), a novel, investigational N‐methyl‐D‐aspartate receptor positive allosteric modulator: Safety, tolerability, and clinical pharmacology in randomized dose‐finding studies in healthy participants and an open‐label study in participants with Huntington's disease
- Published in:
- CTS: Clinical & Translational Science, 2024, v. 17, n. 7, p. 1, doi. 10.1111/cts.13852
- By:
- Publication type:
- Article
5
Pharmacokinetics and tolerability of SRT2104, a first-in-class small molecule activator of SIRT1, after single and repeated oral administration in man.
- Published in:
- British Journal of Clinical Pharmacology, 2013, v. 75, n. 1, p. 186, doi. 10.1111/j.1365-2125.2012.04340.x
- By:
- Publication type:
- Article
6
Population pharmacokinetics of netilmicin in short-term prophylactic treatment.
- Published in:
- British Journal of Clinical Pharmacology, 2003, v. 55, n. 6, p. 552, doi. 10.1046/j.1365-2125.2003.01783.x
- By:
- Publication type:
- Article